|
PREDICT, a study evaluating baseline (BL) disease characteristics predictive of a positive imaging study for distant metastases in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary data. |
| |
|
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen; Millennium; Pfizer; Sanofi |
Research Funding - Carolina Urologic Research Center |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Dendreon; Ferring; Janssen; Millennium; Pfizer; Sanofi |
| |
|
Consulting or Advisory Role - Cardinal Health; Chan Soon-Shiong Institute for Advanced Health; Dendreon; MDxHealth |
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; GHI Pharma; Janssen |
Research Funding - BN ImmunoTherapeutics; CUSP; Dendreon; Janssen; Takeda |
| |
|
No Relationships to Disclose |
| |
Christopher Michael Pieczonka |
Stock and Other Ownership Interests - Titan Medical |
Consulting or Advisory Role - Bayer; Janssen; Myriad Pharmaceuticals |
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst) |
| |
|
Stock and Other Ownership Interests - Dendreon |
Consulting or Advisory Role - Auxilium; Dendreon; Medivation; Teva |
Speakers' Bureau - Auxilium; Dendreon; Medivation; Teva |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Dendreon |
| |
|
|
Stock and Other Ownership Interests - Dendreon |
Consulting or Advisory Role - KinDex |
| |
|
Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen Biotech; MDxHealth; Medivation; Sanofi |
Speakers' Bureau - Dendreon |
Research Funding - Amgen (Inst); Bayer (Inst); Dendreon (Inst); GenomeDx (Inst); Janssen Biotech (Inst); Metabolon (Inst); Mitomics (Inst); Myriad Genetics (Inst); POM Wonderful (Inst); Progenika (Inst) |
Travel, Accommodations, Expenses - Myriad Genetics; Sanofi |